While diabetes treatment and prevention have improved over the past years, the serious lack of proper implementation and monitoring of policies means that Europe is losing the battle against this growing epidemic, according to Diabetes in Europe: Policy Puzzle - The State We AreIn, a report launched today.
The European Health Community wholeheartedly welcomes the announcement of the reversal of the decision by President-elect Jean-Claude Juncker to move the competence for pharmaceutical and medical devices to the enterprise directorate.
Last 14 September, IDF Europe -in collaboration with the Diabetes Education Study Group- held a symposium looking at patient education in a digital world during the 50th EASD Annual Congress in Vienna.
The symposium explored the opportunities to improve patient care and education in an increasingly connected world, as well as discussed how to best implement digital patient education.
IDF Europe has joined the public health community in Europe to send an open letter to Mr Juncker, President-elect of the European Commission, expressing astonishment and concern regarding his decision to move the competence for medicinal products and health technologies from the Commissioner in charge of Health to the Commissioner in charge of internal market and industry.
Parliamentarians, leading diabetes organizations and experts from across Europe have joined forces to form the Policy Action Network on Diabetes (ExPAND) to drive a new generation of policies to address the diabetes epidemic.
Partners of the EConDA project have published their first paper presenting preliminary results of the study.
The Economics of Chronic Diseases (EConDA) project aims to establish the best possible methods of measuring cost-effectiveness as well as develop micro-simulation models apt at projecting future burden of chronic diseases, their costs and potential savings after implementation of cost-effective interventions.